F-18 FDG PET/CT imaging of submandibular gland oncocytoma

Clinical Nuclear Medicine

Volumn 33, Issue 7, 2008, Pages 472-474

  Subramaniam, Rathan M ^a   Durnick, David K ^b   Peller, Patrick J ^a,b  

^a Departments of Radiology   (United States)

^b MAYO CLINIC   (United States)

Author keywords

PET CT; Submandibular oncocytoma

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

AGED; ARTICLE; ASPIRATION BIOPSY; CANCER DIAGNOSIS; CANCER STAGING; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC IMAGING; HUMAN; LIP CARCINOMA; LUNG SMALL CELL CANCER; MALE; METASTASIS; ONCOCYTOMA; SQUAMOUS CELL CARCINOMA; SUBMANDIBULAR GLAND; COMPUTER ASSISTED TOMOGRAPHY; LIP TUMOR; LUNG TUMOR; METHODOLOGY; NEEDLE BIOPSY; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; SALIVARY GLAND TUMOR; SCINTISCANNING;

ADENOMA, OXYPHILIC; AGED, 80 AND OVER; BIOPSY, FINE-NEEDLE; CARCINOMA, SQUAMOUS CELL; FLUORODEOXYGLUCOSE F18; HUMANS; LIP NEOPLASMS; LUNG NEOPLASMS; MALE; NEOPLASM METASTASIS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SUBMANDIBULAR GLAND NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 52249084383     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/RLU.0b013e31817792b6     Document Type: Article

References (13)

1. Batsakis J. Carcinomas of the submandibular and sublingual glands. Ann Otol Rhinol Laryngol. 1986;95:211-212.
2. Shaha A, Webber C, DiMaio T, et al. Needle aspiration biopsy in salivary gland lesions. Am J Surg. 1990;160:373-376.
3. Spiro R. Salivary neoplasms: overview of a 35-year experience with 2,807 patients Head Neck Surg. 1986;8:177-184.
4. Rapidis AD, Stavrianos S, Lagogiannis G, et al. Tumors of the submandibular gland: clinicopathologic analysis of 23 patients. J Oral Maxillofac Surg. 2004;62:1203-1208.
5. Thompson L, Wenign B, Ellis G. Oncocytomas of the submandibular gland. A series of 22 cases and a review of the literature. Cancer. 1996;78:2281-2287.
6. Nagler R, Laufer D. Tumors of the major and minor salivary glands: review of 25 years of experience. Anticancer Res. 1997;17:701-707.
7. Sykes DAJ, Slevin DNJ, Birzgalis MAR, et al. Submandibular gland carcinoma; An audit of local control and survival following adjuvant radiotherapy. Oral Oncol. 1999;35:187-190.
8. Bhattacharyya N. Survival and prognosis for cancer of the submandibular gland. J Oral Maxillofac Surg. 2004;62:427-430.
9. Hagino K, Tsunoda A, Ishihara A, et al. Oncocytoma in the parotid gland presenting a remarkable increase in fluorodeoxyglucose uptake on positron emission tomography. Otolaryngol Head Neck Surg. 2006;134:708-709.
10. Blake MA, McKernan M, Setty B, et al. Renal oncocytoma displaying intense activity on 18F-FDG PET. AJR Am J Roentgenol. 2006;186:269-270.
11. Zimmer L, Branstetter B, Nayak J, et al. Current use of 18Ffluorodeoxyglucose positron emission tomography and combined positron emission tomography and computed tomography in squamous cell carcinoma of the head and neck. Laryngoscope. 2005;115:2029-2034.
12. Roh J-L, Ryu CH, Choi S-H, et al. Clinical utility of 18F-FDG PET for patients with salivary gland malignancies. J Nucl Med. 2007;48:240-246.
13. Nakamoto Y, Tatsumi M, Hammoud D, et al. Normal FDG distribution patterns in the head and neck: PET/CT evaluation. Radiology. 2005;234: 879-885.